CCI approves acquisition of corporate restructuring of GlaxoSmithKline Consumer Healthcare Holdings
The proposed combination involves corporate restructuring of JVCO, including through acquisition by Haleon via demerger and the share exchange steps involving the shareholders of JVCO
CCI | 15/06/2022 | By Sudeep Soparkar | 213
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy